Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
Lara el Hayderi, Fany Colson, Bita Dezfoulian, Arjen F Nikkels Department of Dermatology, CHU du Sart Tilman, University Hospital of Liège, Liège, Belgium Abstract: As TNF-α is a major factor in the immune defense against herpes zoster (HZ); an increased incidence and...
Guardado en:
Autores principales: | el Hayderi L, Colson F, Dezfoulian B, Nikkels AF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bae1aeb098940b7a77500dd42419f0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biologic Treatments of Psoriasis: An Update for the Clinician
por: Brownstone ND, et al.
Publicado: (2021) -
Targeting IL-23 in psoriasis: current perspectives
por: Fotiadou C, et al.
Publicado: (2018) -
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon S, et al.
Publicado: (2017) -
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
por: Beck KM, et al.
Publicado: (2018) -
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado Á, et al.
Publicado: (2018)